CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
7.74
-0.13 (-1.72%)
At close: Jan 9, 2026, 4:00 PM EST
7.85
+0.11 (1.49%)
After-hours: Jan 9, 2026, 5:29 PM EST

CervoMed Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21
711943--
Market Cap Growth
285.58%-55.39%---
Enterprise Value
44-2733--
Last Close Price
7.872.347.63--
PS Ratio
11.381.986.06--
PB Ratio
2.800.495.87--
P/TBV Ratio
2.740.495.87--
EV/Sales Ratio
7.14-4.60--
Debt / Equity Ratio
----1.38-2.74
Asset Turnover
0.160.371.01--
Quick Ratio
6.2310.613.360.311.48
Current Ratio
6.6611.113.840.321.50
Return on Equity (ROE)
-71.42%-69.95%---
Return on Assets (ROA)
-42.78%-42.95%-69.12%-39.59%-
Return on Capital (ROIC)
-47.46%-48.91%-90.49%-44.40%-
Return on Capital Employed (ROCE)
-104.60%-46.50%-105.90%38.60%-223.00%
Earnings Yield
-35.89%-84.35%-5.02%--
Buyback Yield / Dilution
-19.30%-203.34%-413.65%88.49%-
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q